Review
Open access
Sep 2026
Biomarkers in Clear Cell Renal Cell Carcinoma: From Biological Association to Clinical Decision-Making
This review evaluates biomarkers at three clinical decision points: characterization of an indeterminate renal mass; recurrence-risk assessment and adjuvant treatment selection after nephrectomy; and first-line regimen selection in metastatic ccRCC.
Hadi Al Etri, Lea Al Zoghby, Mohamad Sadek Zoghbi et al.
· Genes · 0 citations